Predicting a response to FOLFIRINOX in pancreatic cancer

J Natl Cancer Inst. 2015 May 29;107(8):djv175. doi: 10.1093/jnci/djv175. Print 2015 Aug.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Camptothecin / analogs & derivatives*
  • Carboxylesterase / metabolism*
  • Carcinoma, Pancreatic Ductal / drug therapy*
  • Carcinoma, Pancreatic Ductal / enzymology*
  • Female
  • Humans
  • Male
  • Pancreatic Neoplasms / drug therapy*
  • Pancreatic Neoplasms / enzymology*

Substances

  • Carboxylesterase
  • Camptothecin